Abstract

The etiological structure of opportunistic infections of the urinary tract represented by bacteria of the Enterobacteriaceae family (with a predominance of Escherichia coli, Klepsiella pneumoniae), as well as non-fermenting gram-negative bacteria (Acinetobacter baumanii, Pseudomonas) and staphylococci and enterococcus etc. were revealed in the result of the research. The antibiotic sensitivity of urinary tract infection pathogens to the most commonly used antibiotics were studied, also the antibiotic resistance of E. coli and K. pneumoniae to co-trimoxazole, fluoroquinolones, carbapenems, cephalosporins of the 1st and 2nd generation and resistance of A. baumanii and P. aeruginosa to fluoroquinolones, carbapenems, as well as VRE and MRSA were studied. The study and selection of new herbal medicines were carried out. The 10% solution of Geranium collinum Steph and Rosmarinus officinalis L. had the highest microbiological properties which can be used in the treatment of urinary tract infection.

Highlights

  • Ключевые слова: антибиотикорезистентные штаммы, растительные препараты, инфекции мочевыводящих путей, MRSA, VRE, Geranium collinum Steph., Rosmarinus officinalis L

  • Результаты исследований От обследованных пациентов с клиническими признаками инфекции мочевыводящих путей (ИМП) были выделены 280 культур микроорганизмов, из которых 110 отнесены к бактериям семейства Enterobacteriaceae с преобладанием E. coli — 32% и K. pneumoniae — 25%), остальные были идентифицированы и отнесены к неферментирующим грамотрицательным бактериям (P. aeruginosa — 5,8%, Acinetobacter — 3,5%), а также к Стафилококкам (28%) и Энтерококкам (4,8%) и др. (Рисунок)

  • The asymptomatic bacteriuria Escherichia coli strain 83972 outcompetes uropathogenic E. coli strains in human urine // Infection and immunity. 2006

Read more

Summary

OF OVERCOMING THEIR ANTIBIOTIC RESISTANCE

©Narimanov V., Azerbaijan Medical University, Baku, Azerbaijan ©Gurbanova S., Azerbaijan Medical University, Baku, Azerbaijan.

Стафилококки Энтерококки
Findings
Антибиотикорезистентные штаммы

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.